Cystic Fibrosis Research - Symptoms, Genetics, Treatment, Information

Cystic Fibrosis Research Today is a free monthly online journal that collates and summarizes the latest research about Cystic Fibrosis, including details on symptoms, genetics, treatment, information.


Cystic Fibrosis Research Today

Home

View Latest Issue

Information About Cystic Fibrosis

Books on Cystic Fibrosis

Advertising in Research Today

View Other Research Today Publications



Volume 4 (2007), Issue 4 (April)

  1. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Pediatr Pulmonol, 42(4): 307-13. [Abstract] [Full-text]
  2. Potential role of the cellular allergen stimulation test (CAST) in diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis.
    Pediatr Pulmonol, 42(4): 314-8. [Abstract] [Full-text]
  3. Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site.
    J Biol Chem, 282(14): 10804-13. [Abstract] [Full-text]
  4. Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum.
    Eur Respir J, 29(4): 624-32. [Abstract] [Full-text]
  5. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR.
    Clin Chim Acta, 380(1): 122-7. [Abstract] [Full-text]
  6. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Am J Respir Crit Care Med, 175(8): 816-21. [Abstract] [Full-text]
  7. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
    Am J Respir Crit Care Med, 175(8): 822-8. [Abstract] [Full-text]
  8. Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells.
    Biochem Biophys Res Commun, 356(3): 745-9. [Abstract] [Full-text]
  9. The expression of the mitochondrial gene MT-ND4 is downregulated in cystic fibrosis.
    Biochem Biophys Res Commun, 356(3): 805-9. [Abstract] [Full-text]
  10. Nutritional management of cystic fibrosis patients.
    Curr Opin Clin Nutr Metab Care, 10(3): 348-54. [Abstract] [Full-text]
  11. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.
    Lancet, 369(9568): 1187-95. [Abstract] [Full-text]
  12. Cardiopulmonary bypass for lung transplantation in cystic fibrosis: pilot evaluation of perioperative outcome.
    J Cardiothorac Vasc Anesth, 21(2): 208-11. [Abstract] [Full-text]
  13. Special considerations for patients with cystic fibrosis undergoing lung transplantation.
    Chest, 131(4): 1224-31. [Abstract] [Full-text]
  14. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    Chest, 131(4): 1188-96. [Abstract] [Full-text]
  15. Effect of albuterol on maximal exercise capacity in cystic fibrosis.
    Chest, 131(4): 1181-7. [Abstract] [Full-text]
  16. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Expert Rev Proteomics, 4(2): 199-209. [Abstract] [Full-text]
  17. Prediction of cellular immune responses against CFTR in patients with cystic fibrosis after gene therapy.
    Am J Respir Cell Mol Biol, 36(5): 529-33. [Abstract] [Full-text]
  18. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Am J Respir Cell Mol Biol, 36(5): 615-24. [Abstract] [Full-text]
  19. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
    BMC Med, 5: 5. [Abstract] [Full-text]
  20. Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR.
    Br J Pharmacol, 150(8): 1055-65. [Abstract] [Full-text]
  21. ICAM-1 expression on conjunctival epithelial cells in patients with cystic fibrosis.
    Cytometry B Clin Cytom, 72(3): 204-8. [Abstract] [Full-text]
  22. Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epithelia.
    J Physiol, 580: 577-92. [Abstract] [Full-text]
  23. Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.
    J Bacteriol, 189(9): 3665-8. [Abstract] [Full-text]
  24. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
  25. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Infect Immun, 75(5): 2214-24. [Abstract] [Full-text]
  26. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
    J Med Microbiol, 56: 670-4. [Abstract] [Full-text]
  27. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.
    Am J Respir Crit Care Med, 175(9): 943-50. [Abstract] [Full-text]
  28. Low bone mineral density in young children with cystic fibrosis.
    Am J Respir Crit Care Med, 175(9): 951-7. [Abstract] [Full-text]
  29. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
    Clin Biochem, 40(8): 511-20. [Abstract] [Full-text]
  30. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.
    J Cyst Fibros, 6(3): 228-33. [Abstract] [Full-text]
  31. Partial Splenic Embolization: successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis.
    J Cyst Fibros, 6(3): 212-4. [Abstract] [Full-text]
  32. Work disability in adults with cystic fibrosis and its relationship to quality of life.
    J Cyst Fibros, 6(3): 223-7. [Abstract] [Full-text]
  33. Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis.
    J Cyst Fibros, 6(3): 215-9. [Abstract] [Full-text]
  34. N1303K and IVS8-5T, clinical presentation within a family with atypical cystic fibrosis.
    J Cyst Fibros, 6(3): 220-2. [Abstract] [Full-text]
  35. Cystic fibrosis related diabetes in an extremely young patient.
    J Cyst Fibros, 6(3): 247-9. [Abstract] [Full-text]
  36. Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results on parents.
    J Cyst Fibros, 6(3): 250-4. [Abstract] [Full-text]
  37. Fosfomycin--investigation of a possible new route of administration of an old drug. A case study.
    J Cyst Fibros, 6(3): 244-6. [Abstract] [Full-text]
  38. Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin.
    J Cyst Fibros, 6(3): 209-11. [Abstract] [Full-text]
  39. A specific database for providing local and national level of integration of clinical data in cystic fibrosis.
    J Cyst Fibros, 6(3): 187-93. [Abstract] [Full-text]
  40. Facial nerve palsy associated with a low serum vitamin A level in an infant with cystic fibrosis.
    J Cyst Fibros, 6(3): 241-3. [Abstract] [Full-text]
  41. Restless leg syndrome manifested by iron deficiency from chronic hemoptysis in cystic fibrosis.
    J Cyst Fibros, 6(3): 234-6. [Abstract] [Full-text]
  42. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
    J Cyst Fibros, 6(3): 237-40. [Abstract] [Full-text]
  43. CFTR gene analysis in Latin American CF patients: heterogeneous origin and distribution of mutations across the continent.
    J Cyst Fibros, 6(3): 194-208. [Abstract] [Full-text]
  44. Cystic fibrosis mortality trends in France.
    J Cyst Fibros, 6(3): 179-86. [Abstract] [Full-text]
  45. Adherence of adult cystic fibrosis patients with airway clearance and exercise regimens.
    J Cyst Fibros, 6(3): 163-70. [Abstract] [Full-text]
  46. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results.
    J Cyst Fibros, 6(3): 171-8. [Abstract] [Full-text]
  47. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Pediatr Pulmonol, 42(5): 471-6. [Abstract] [Full-text]
  48. Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling.
    Biochem Biophys Res Commun, 357(2): 402-7. [Abstract] [Full-text]
  49. Liver disease as risk factor for cystic fibrosis-related diabetes development.
    Acta Paediatr, 96(5): 736-9. [Abstract] [Full-text]
  50. Current issues in quality improvement in cystic fibrosis.
    Clin Chest Med, 28(2): 459-72. [Abstract] [Full-text]
  51. Advances in lung transplantation for patients who have cystic fibrosis.
    Clin Chest Med, 28(2): 445-57. [Abstract] [Full-text]
  52. Fertility and pregnancy: common concerns of the aging cystic fibrosis population.
    Clin Chest Med, 28(2): 433-43. [Abstract] [Full-text]
  53. Transition and transfer of patients who have cystic fibrosis to adult care.
    Clin Chest Med, 28(2): 423-32. [Abstract] [Full-text]
  54. Imaging of the chest in cystic fibrosis.
    Clin Chest Med, 28(2): 405-21. [Abstract] [Full-text]
  55. Infection control practice in cystic fibrosis centers.
    Clin Chest Med, 28(2): 381-404. [Abstract] [Full-text]
  56. Novel therapies for the treatment of cystic fibrosis: new developments in gene and stem cell therapy.
    Clin Chest Med, 28(2): 361-79. [Abstract] [Full-text]
  57. Macrolides in cystic fibrosis.
    Clin Chest Med, 28(2): 347-60. [Abstract] [Full-text]
  58. Inflammation and anti-inflammatory therapies for cystic fibrosis.
    Clin Chest Med, 28(2): 331-46. [Abstract] [Full-text]
  59. Nutrition and lung disease in cystic fibrosis.
    Clin Chest Med, 28(2): 319-30. [Abstract] [Full-text]
  60. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Clin Chest Med, 28(2): 307-18. [Abstract] [Full-text]
  61. Newborn screening for cystic fibrosis.
    Clin Chest Med, 28(2): 297-305. [Abstract] [Full-text]
  62. Pathogenesis of bronchiectasis.
    Clin Chest Med, 28(2): 289-96. [Abstract] [Full-text]
  63. Cystic fibrosis: a review of epidemiology and pathobiology.
    Clin Chest Med, 28(2): 279-88. [Abstract] [Full-text]
  64. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation.
    Diabetes Care, 30(5): 1187-92. [Abstract] [Full-text]
  65. Microvascular complications in cystic fibrosis-related diabetes.
    Diabetes Care, 30(5): 1056-61. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Cystic Fibrosis Research Today. All Rights Reserved.



Cystic Fibrosis Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)



Cystic Fibrosis Books

David's Promise: A Young Man's Struggle with Cystic Fibrosis

David's Promise: A Young Man's Struggle with Cystic Fibrosis